So sánh giữa chụp MRI trừ và chụp MRI động trong việc đánh giá đáp ứng điều trị sau khi áp dụng đốt sóng cao tần ở bệnh nhân ung thư biểu mô tế bào gan
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ozkavukcu E, Haliloğlu N, Erden A (2009) Post-treatment MRI findings of hepatocellular carcinoma. Diagn Interv Radiol 15:111–120
Gaia S, Ciruolo M, Ribaldone DG et al (2021) Higher efficiency of percutaneous microwave (MWA) than radiofrequency ablation (RFA) in achieving complete response in cirrhotic patients with early hepatocellular carcinoma. Curr Oncol 28:1034–1044
Yoshida H, Taniai N, Yoshioka M et al (2019) Current status of laparoscopic hepatectomy. J Nippon Med Sch 86:201–206
Bréhier G, Besnier L, Delagnes A et al (2021) Imaging after percutaneous thermal and non-thermal ablation of hepatic tumour: normal appearances, progression and complications. Br J Radiol. https://doi.org/10.1259/bjr.20201327
Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM (2010) Liver ablation techniques: a review. Surg Endosc 24:254–265
Kuehl H, Antoch G, Stergar H et al (2008) Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 67:362–371
Sainani NI, Gervais DA, Mueller PR, Arellano RS (2013) Imaging after percutaneous radiofrequency ablation of hepatic tumors: part 1, normal findings. Am J Roentgenol 200:184–193
Sainani NI, Gervais DA, Mueller PR, Arellano RS (2013) Imaging after percutaneous radiofrequency ablation of hepatic tumors: part 2, abnormal findings. Am J Roentgenol 200:194–204
European Association For The Study Of The Liver; European Organization For Research And Treatment Of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
Kele PG, van der Jagt EJ (2010) Diffusion weighted imaging in the liver. World J Gastroenterol 16:1567–1576
Thng CH, Koh TS, Collins DJ, Koh DM (2010) Perfusion magnetic resonance imaging of the liver. World J Gastroenterol 16:1598–1609
Newatia A, Khatri G, Friedman B, Hines J (2007) Subtraction imaging: applications for nonvascular abdominal MRI. Am J Roentgenol 188:1018–1025
Chopro S, Dodd GD 3rd, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H (2001) Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. Am J Roentgenol 177:381–387
Winters SD, Jackson S, Armstrong GA, Birchall IW, Lee KH, Low G (2012) Value of subtraction MRI in assessing treatment response following image-guided loco-regional therapies for hepatocellular carcinoma. Clin Radiol 67:649–655
Dromain C, de Baere T, Elias D et al (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262
Hussain HK, Syed I, Nghiem HV et al (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230:637–644
Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DS (2003) Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. Am J Roentgenol 181:1635–1640
Kierans AS, Elazzazi M, Braga L et al (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. Am J Roentgenol 194:523–529
Abddallah MFH, Desouky SHI, Madbouly M et al (2021) Follow-up after radiofrequency ablation of hepatocellular carcinoma: diffusion weighted and dynamic contrast enhanced MRI characteristics. Med J Cairo Univ 89:297–305
Vincenza G, Mario P, Roberta F et al (2013) Surveillance of HCC patients after liver RFA: role of MRI with hepatospecific contrast versus three-phase CT scan-experience of high volume oncologic institute. Gastroenterolo Res Pract. https://doi.org/10.1155/2013/469097